Comparison of the X-radiation, drug and ultraviolet-radiation responses of clones isolated from a human colorectal tumor cell line

Radiation Research

Volumn 161, Issue 3, 2004, Pages 326-334

  Qutob, Sami S ^a,b   Multani, Asha S ^c   Pathak, S ^c   Feng, Y ^a   Kendal, Wayne S ^a   Ng, Cheng E ^a,b  

^a OTTAWA REGIONAL CANCER CENTRE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CISPLATIN; ETOPOSIDE; TOPOTECAN;

ARTICLE; CELL SURVIVAL; CHROMATID; CHROMOSOME BREAKAGE; CHROMOSOME G BAND; CLONE; COLORECTAL TUMOR; COMPARATIVE STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; METAPHASE; NUDE MOUSE; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION DOSE FRACTIONATION; RADIOSENSITIVITY; TELOMERE; TUMOR CELL LINE; ULTRAVIOLET RADIATION; X RAY; CELL DIVISION; DOSE RESPONSE; DRUG EFFECT; DRUG RESISTANCE; EVALUATION; GENETICS; METHODOLOGY; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PATHOLOGY; RADIATION DOSE; RADIATION EXPOSURE; RADIATION RESPONSE; SENSITIVITY AND SPECIFICITY;

ANTINEOPLASTIC AGENTS; CELL DIVISION; CELL LINE, TUMOR; CELL SURVIVAL; CLONING, MOLECULAR; COLORECTAL NEOPLASMS; DNA MUTATIONAL ANALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG RESISTANCE; HUMANS; RADIATION TOLERANCE; SENSITIVITY AND SPECIFICITY; ULTRAVIOLET RAYS; X-RAYS;

EID: 2442661921     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR3144     Document Type: Article

References (40)

1. I. Savre-Train, L. S. Gollahon and S. E. Holt, Clonal heterogeneity in telomerase activity and telomere length in tumor-derived cell lines. Proc. Soc. Exp. Biol. Med. 223, 379-388 (2000).
2. G. H. Zhou, G. L. Sechrist, M. G. Brattain and K. M. Mulder, Clonal heterogeneity of the sensitivity of human colon carcinoma cell lines to TGFβ isoforms. J. Cell Physiol. 165, 512-520 (1995).
3. V. Falanga, L. H. Zhou, H. Takagi, H. Murata, S. Ochoa, T. A. Martin and T. Helfman, Human dermal fibroblast clones derived from single cells are heterogeneous in the production of mRNAs for alpha 1(1) procollagen and transforming growth factor-β1. J. Invest. Dermatol. 105, 27-31 (1995).
4. R. Kumar, R. K. Tiwari, J. Kusari and G. C. Sen, Clonal derivatives of the RD-114 cell line differ in their antiviral and gene-inducing responses to interferons. J. Virol. 61, 2727-2732 (1987).
5. J. K. Wei, R. Kodym and C. Jin, Radioresistant cell strain of human fibrosarcoma cells obtained after long-term exposure to x-rays. Radiat. Environ. Biophys. 37, 133-137 (1998).
6. J. Russell, T. E. Wheldon and P. A. Stanton, radioresistant variant derived from a human neuroblastoma cell line is less prone to radiation-induced apoptosis. Cancer Res. 55, 4915-4921 (1995).
7. M. Fitzek and K. R. Trott, Clonal heterogeneity in delayed decrease of plating efficiency of irradiated HeLa cells. Radiat. Environ. Biophys. 32, 33-39 (1993).
8. D. R. Welch, L. Milas, S. P. Tomasovic and G. L. Nicolson, Heterogeneous response and clonal drift of sensitivities of metastatic 13762NF mammary adenocarcinoma clones to gamma-radiation in vitro. Cancer Res. 43, 6-10 (1983).
9. D. C. Brown and K. R. Trott, Clonal heterogeneity in the progeny of HeLa cells which survive X-irradiation. Int. J. Radiat. Biol. 66, 151-155 (1994).
10. S. Powell and T. J. McMillan, Clonal variation of DNA repair in a human glioma cell line. Radiother. Oncol. 21, 225-232 (1991).
11. J. T. Leith, D. L. Dexter, J. K. DeWyngaert, E. M. Zeman, M. Y. Chu, P. Calabresi and A. S. Glicksman, Differential responses to x-irradiation of subpopulations of two heterogeneous human carcinomas in vitro. Cancer Res. 42, 2556-2561 (1982).
12. 1 arrest in human cancer cells. Cancer Res. 55, 5187-5190 (1995).
13. C. E. Ng, A. M. Bussey and G. P. Raaphorst, Inhibition of potentially lethal and sublethal damage repair by camptothecin and etoposide in human melanoma cell lines. Int. J. Radiat. Biol. 66, 49-57 (1994).
14. E. J. Hall, Radiobiology for the Radiologist, 4th ed. J. B. Lippincott, Philadelphia, 1994.
15. S. Pathak, Chromosome banding techniques. J. Reprod. Med. 17, 25-28 (1976).
16. A. S. Multani, M. Ozen, C. L. Furlong, Y-J. Zhao, T. C. Hsu and S. Pathak, Heterochromatin and interstitial telomeric DNA homology. Chromosoma 110, 214-220 (2001).
17. J. S. Bedford and W. C. Dewey, Historical and current highlights in radiation biology: Has anything important been learned by irradiating cells? Radiat. Res. 158, 251-291 (2002).
18. H. L. Flyger, J. K. Larsen, H. J. Nielsen and I. J. Christensen, DNA ploidy in colorectal cancer, heterogeneity within and between tumors and relation to survival. Cytometry 38, 293-300 (1999).
19. G. Bardi, L. A. Parada, L. Bomme, N. Pandis, B. Johansson, R. Willen, C. Fenger, O. Kronborg, F. Mitelman and S. Heim, Cytogenetic findings in metastases from colorectal cancer. Int. J. Cancer 72, 604-607 (1997).
20. A. Buronfosse, C. P. Thomas, C. Ginestet and J. F. Dore, Radiosensitivity in vitro of clonogenic and non-clonogenic glioblastoma cells obtained from a human brain tumour. C. R. Acad. Sci. III 317, 1031-41 (1994).
21. M. G. Brattain, W. D. Fine, F. M. Khaled, J. Thompson and D. E. Brattain, Heterogeneity of malignant cells from a human colonic carcinoma. Cancer Res. 41, 1751-1756 (1981).
22. G. Poste, J. Tzeng, J. Doll, R. Greig, D. Rieman and I. Zeidman, Evolution of tumor cell heterogeneity during progressive growth of individual lung metastases. Proc. Natl. Acad. Sci. USA 79, 6574-6578 (1982).
23. R. Becher, T. Buchner, C. D. Bloomfield, W. Hiddemann, D. K. Hossfield and J. Schumann, Tumor Aneuploidy, Springer-Verlag, New York, 1985.
24. S. Pathak, Cytogenetic abnormalities in cancer: With special emphasis on tumor heterogeneity. Cancer Metastasis Rev. 8, 299-318 (1990).
25. I. J. Fidler and I. R. Hart, Biologic diversity in metastatic neoplasms: Origins and implications. Science 194, 23-25 (1982).
26. K. R. Trott, The mechanisms of acceleration of repopulation in squamous epithelia during daily irradiation. Acta Oncol. 38, 153-157 (1999).
27. W. Budach, D. Gioioso, A. Taghian, M. Stuschke and H. D. Suit, Repopulation capacity during fractionated irradiation of squamous cell carcinomas and glioblastomas in vitro. Int. J. Radiat. Oncol. Biol. Phys. 39, 743-750 (1997).
28. Catalog of Cell Lines and Hybridomas, 7th ed. American Type Culture Collection, Manassas, VA, 1992.
29. F. M. Mesak, N. Osada, K. Hashimoto, Q. Y. Liu and C. E. Ng, Molecular cloning, genomic characterization and over-expression of a novel gene, XRRA1, identified from human colorectal cancer cell HCT116Clone2_XRR and macaque testis. BMC Genomics 4, 32 (2003).
30. S. D. Bouffler, M. A. Blasco, R. Cox and P. J. Smith, Telomeric sequences, radiation sensitivity and genomic instability. Int. J. Radial. Biol. 77, 995-1005 (2001).
31. J. McIlrath, S. D. Bouffler, E. Samper, A. Cuthbert, A. Wojcik, I. Szumiel, P. E. Bryant, A. C. Riches, A. Thompson and P. Slijepcevic, Telomere length abnormalities in mammalian radiosensitive cells. Cancer Res. 61, 912-915 (2001).
32. M. Potmesil and H. E. Pinedo, Camptothecins: New Anticancer Agents. CRC Press, Boca Raton, FL, 1995.
33. P. Frit, Y. Canitrot, C. Muller, N. Foray, P. Calsou, E. Marangoni, J. Bourhis and B. Salles, Cross-resistance to ionizing radiation in a murine leukemic cell line resistant to cis-dichlorodiammineplatinum(II): Role of Ku autoantigen. Mol. Pharmacol. 56, 141-146 (1999).
34. G. P. Raaphorst, D. E. Wilkins, J. P. Mao, J. C. Miao and C. E. Ng, Evaluation of cross-resistance between responses to cisplatin, hyperthermia, and radiation in human glioma cells and eight clones selected for cisplatin resistance. Radiat. Oncol. Investig. 7, 153-157 (1999).
35. J. L. Schwartz, J. Rotmensch, M. A. Beckett, D. R. Jaffe, M. Toohill, S. M. Giovanazzi, J. McIntosh and R. R. Weichselbaum, X-ray and cis-diamminedichloroplatinum(II) cross-resistance in human tumor cell lines. Cancer Res. 48, 5133-5 (1988).
36. R. F. Ozols, T. C. Hamilton, E. Reed, M. C. Poirier, H. Masuda, G. Lai and R. C. Young, High dose cisplatin and drug resistance: Clinical and laboratory correlations. Dev. Oncol. 54, 197-206 (1988).
37. C. C. Chao, S. L. Huang, H. M. Huang and S. Lin-Chao, Cross-resistance to UV radiation of a cisplatin-resistant human cell line: Overexpression of cellular factors that recognize UV-modified DNA. Mol. Cell Biol. 11, 2075-2080 (1991).
38. W. C. Dempke, S. A. Shellard, L. K. Hosking, A. M. Fichtinger-Schepman and B. T. Hill, Mechanisms associated with the expression of cisplatin resistance in a human ovarian tumor cell line following exposure to fractionated X-irradiation in vitro. Carcinogenesis 13, 1209-1215 (1992).
39. R. F. Ozols, H. Masuda and T. C. Hamilton, Mechanisms of cross-resistance between radiation and antineoplastic drugs. NCI Monogr. 159-165 (1988).
40. R. W. Johnstone, A. A. Ruefli and S. W. Lowe, Apoptosis: A link between cancer genetics and chemotherapy. Cell 108, 153-164 (2002).